A next-generation inhalable dry powder COVID vaccine

Zhou Xing () and Mangalakumari Jeyanathan ()

Nature, 2023, vol. 624, issue 7992, 532-534

Abstract: Current injectable COVID-19 vaccines are unable to induce robust immunity in the mucosal tissues lining the airways. A protein-based vaccine delivered to the lungs in the form of an inhaled dry powder shows promise as a way forward.

Keywords: SARS-CoV-2; Vaccines; Medical research; Immunology (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-03557-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:624:y:2023:i:7992:d:10.1038_d41586-023-03557-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-03557-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().